Atlas Trials

Dose Modification Requirement for Trelagliptin in Egyptian Population

Clinical trial NCT04374864 · UNKNOWN

Trial details

NCT number
NCT04374864
Sponsor
British University In Egypt
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2020-03-01
Primary completion
2020-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.